av/unicycive-therapeutics--big.svg

COM:UNICYCIVE

Unicycive

  • Stock

Last Close

0.53

22/11 21:00

Market Cap

41.21M

Beta: -

Volume Today

841.15K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-2.17M
-
-2.26M
4.57%
-10.02M
342.45%
-18.06M
80.27%
-30.54M
69.14%
depreciation and amortization
13K
-
161K
1,138.46%
284K
76.40%
deferred income tax
127K
-
stock based compensation
24K
-
232K
866.67%
966K
316.38%
1.05M
8.39%
1.77M
68.77%
change in working capital
305K
-
-166K
154.43%
-105K
36.75%
1.18M
1,221.90%
1.28M
8.32%
accounts receivables
inventory
accounts payables
308K
-
-68K
122.08%
1.24M
1,925%
1.27M
2.10%
1.28M
0.71%
other working capital
-3K
-
-98K
3,166.67%
-1.35M
1,273.47%
-89K
93.39%
-1.28M
1,333.71%
other non cash items
660K
-
739K
11.97%
3.25M
339.65%
21K
99.35%
10.21M
48,519.05%
net cash provided by operating activities
-1.18M
-
-1.46M
24.06%
-5.77M
295.27%
-15.65M
171.39%
-18.28M
16.82%
investments in property plant and equipment
-29K
-
-2K
93.10%
-12K
500%
acquisitions net
purchases of investments
sales maturities of investments
other investing activites
net cash used for investing activites
-29K
-
-2K
93.10%
-12K
500%
debt repayment
-9K
-
-160K
1,677.78%
-1.36M
750.63%
common stock issued
1.17M
-
141K
87.91%
22.27M
15,695.04%
11K
99.95%
30.19M
274,354.55%
common stock repurchased
dividends paid
-867K
-
other financing activites
9K
-
1.46M
16,155.56%
1.47M
0.14%
-482K
132.90%
-1.78M
269.71%
net cash used provided by financing activities
1.17M
-
1.44M
23.84%
22.38M
1,449.52%
-471K
102.11%
27.54M
5,947.35%
effect of forex changes on cash
net change in cash
-10K
-
-15K
50%
16.58M
110,626.67%
-16.12M
197.26%
9.25M
157.34%
cash at beginning of period
25K
-
15K
40%
16.58M
-
455K
97.26%
cash at end of period
15K
-
16.58M
-
455K
97.26%
9.70M
2,032.09%
operating cash flow
-1.18M
-
-1.46M
24.06%
-5.77M
295.27%
-15.65M
171.39%
-18.28M
16.82%
capital expenditure
-29K
-
-2K
93.10%
-12K
500%
free cash flow
-1.18M
-
-1.46M
24.06%
-5.80M
297.26%
-15.65M
170.07%
-18.30M
16.88%

All numbers in (except ratios and percentages)